We are live on ! Find out more
RB

Richmond Brothers Portfolio holdings

AUM $150M
1-Year Est. Return 14.02%
This Fund
S&P 500
This Quarter Est. Return
-2.41%
1 Year Est. Return
+14.02%
3 Year Est. Return
+102.97%
5 Year Est. Return
10 Year Est. Return
AUM
$53.2M
AUM Growth
-$8.51M
Cap. Flow
-$5.8M
Cap. Flow %
-10.9%
Top 10 Hldgs %
92.72%
Holding
25
New
3
Increased
6
Reduced
14
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 26.15%
2 Technology 14.18%
3 Financials 10.16%
4 Consumer Discretionary 1.56%
5 Communication Services 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$453B
$16.7M 31.4%
46,638
-4,525
-9% -$1.68M
MDXG icon
2
MiMedx Group
MDXG
$602M
$10.8M 20.28%
1,481,332
-105,168
-7% -$783K
AAPL icon
3
Apple
AAPL
$4.54T
$5.89M 11.06%
34,395
-3,994
-10% -$732K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.41M 10.16%
15,440
-2,781
-15% -$987K
GOF icon
5
Guggenheim Strategic Opportunities Fund
GOF
$2.23B
$3.86M 7.24%
260,700
+2,040
+0.8% +$32.2K
MSFT icon
6
Microsoft
MSFT
$3.45T
$1.66M 3.11%
5,247
-1,920
-27% -$634K
ARKK icon
7
ARK Innovation ETF
ARKK
$5.64B
$1.53M 2.87%
38,540
-11,592
-23% -$511K
IBB icon
8
iShares Biotechnology ETF
IBB
$9.34B
$1.42M 2.67%
11,616
-1,794
-13% -$228K
IRD
9
Opus Genetics
IRD
$306M
$1.23M 2.32%
368,003
+26,143
+8% +$105K
RMTI icon
10
Rockwell Medical
RMTI
$28.4M
$854K 1.6%
41,035
-1,227
-3% -$37.3K
NVG icon
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$591K 1.11%
57,336
-5,115
-8% -$57.6K
AMZN icon
12
Amazon
AMZN
$2.92T
$490K 0.92%
3,855
+97
+3% +$13K
IVV icon
13
iShares Core S&P 500 ETF
IVV
$878B
$395K 0.74%
919
+14
+2% +$6.26K
MCD icon
14
McDonald's
MCD
$192B
$339K 0.64%
1,287
-254
-16% -$72.4K
AIRI icon
15
Air Industries Group
AIRI
$13M
$320K 0.6%
111,319
-16,571
-13% -$52.5K
APLT
16
DELISTED
Applied Therapeutics
APLT
$308K 0.58%
+123,654
New +$204K
AXNX
17
DELISTED
Axonics, Inc. Common Stock
AXNX
$267K 0.5%
+4,749
New +$267K
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.36T
$261K 0.49%
1,980
-1,820
-48% -$237K
PG icon
19
Procter & Gamble
PG
$336B
$226K 0.42%
1,549
-53
-3% -$8.1K
JNJ icon
20
Johnson & Johnson
JNJ
$618B
$210K 0.4%
1,349
VZ icon
21
Verizon
VZ
$195B
$206K 0.39%
6,342
-811
-11% -$27.4K
ONCT
22
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$148K 0.28%
24,702
+10,150
+70% +$71.5K
HRTX icon
23
Heron Therapeutics
HRTX
$93.9M
$106K 0.2%
103,009
+60,604
+143% +$86.3K
CRGE
24
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$9.94K 0.02%
+20,000
New +$15K
PSP icon
25
Invesco Global Listed Private Equity ETF
PSP
$232M
-10,578
Closed -$556K

Similar funds

Richmond Brothers's Q3 2023 Portfolio in Review

As of Q3 2023, Richmond Brothers held 25 positions worth $53.2M, down 14% from $61.8M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Richmond Brothers withdrew a net $5.8M in Q3 2023, closing 1 position and reducing 14 holdings. Its most notable exit was Invesco Global Listed Private Equity ETF, an estimated $556K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Richmond Brothers opened a new position in Axonics, Inc. Common Stock worth $267K.

  • Richmond Brothers's largest Q3 2023 buy was Axonics, Inc. Common Stock: 4,749 shares worth $267K.
  • Richmond Brothers added most to Opus Genetics in Q3 2023, an estimated $105K increase.
  • Richmond Brothers's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.68M.
  • Richmond Brothers fully exited Invesco Global Listed Private Equity ETF in Q3 2023, selling an estimated $556K.
  • Richmond Brothers's ten largest holdings make up 93% of its $53.2M portfolio in Q3 2023.
  • Richmond Brothers opened 3 new positions and closed 1 in Q3 2023.
  • Richmond Brothers's portfolio value fell 14% quarter-over-quarter to $53.2M.

Based on Richmond Brothers's 13F filing for Q3 2023, filed 3 Nov 2023.